Real-time enrollment status for this biliary tract cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06109779 |
| Recruiting Status | Recruiting |
| Condition | Biliary Tract Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 750 participants |
| Active Locations | 34 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | November 26, 2025 (Nov 26, 2025) |
As of March 2, 2026: Clinical trial NCT06109779 is currently recruiting participants. This clinical trial study for biliary tract cancer is actively seeking new participants at 34 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06109779 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06109779 was last updated Nov 26, 2025 (November 26, 2025). HelloStudys verifies this status automatically.